Clinical Trial Update: Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for neo-adjuvant chemotherapy in triple negative breast cancer spanning Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING